Ischemic stroke is a complex condition influenced by inflammatory process, environmental risk factors, and genetic factors. Identification of these risk factors and their relationships are critical in the understanding of the pathogenesis and etiology, diagnosis, and treatment of this condition[1-5].
INTRODUCTION
Background : Ischemic stroke is a complex condition influenced by many factors. Previous studies have demonstrated that inflammatory markers might play a role in such vascular diseases. Therefore the purpose of this study was to compare the expression of inflammatory markers in Korean ischemic stroke patients and to investigate their relationship to APOE polymorphism.
Methods : The patient group consisted of 275 patients with large artery atherosclerosis (LAA, n= 169) and small artery occlusion (SAO, n=106). One hundred and nineteen age matched healthy subjects were recruited as the control group. Serum levels of three inflammatory markers (matrix metalloproteinase, MMP-9; tissue inhibitor of metalloproteinase-1, TIMP-1; and high-sensitivity C-reactive protein, hs-CRP) were measured in each patient by using commercially available kits. Comparison of clinical risk factors, inflammatory marker levels, and APOE genotypes between the stroke patient group and control group and between the two patient subgroups was assessed.
Results : Comparison of the stroke group to control group showed significantly elevated levels of circulating MMP-9 (P<0.01) and hs-CRP (P=0.01). Comparison between the individual subgroups revealed a significantly higher level of only TIMP-1 in the LAA subgroup compared to the SAO subgroup (P<0.01). There was no significant difference in inflammatory marker levels among each allele carrier.
Conclusions : The present study revealed the obvious tendency of increased circulating inflammatory markers in the patients with acute ischemic attack, especially MMP-9 and hs-CRP. Our observations suggest that measurement of serum MMP-9, TIMP-1, and hs-CRP levels may be useful in the diagnosis of ischemic stroke patients. (Korean J Lab Med 2007; 27:197-204) 
One known genetic factor, the apolipoprotein E (apoE), has exhibited a central role in influencing the inflammatory response [6, 7] . It has also been postulated that certain apoE alleles are a risk factor for the initiation and/or development of atherosclerosis [8, 9] . However, in discrepancy to the previous reports, case-control studies in the Korean population showed controversial results. Some reports announced that apoE 4 allele was not associated to ischemic stroke [10] . A recent study revealed a strong association of the apoE 4 allele to ischemic stroke but did not show an association between specific apoE alleles and atherosclerosis in subtypes of ischemic stroke with different pathogenesis [11] . Therefore, the presence of other effects resulting in atherosclerosis is strongly suspected.
Inflammatory markers, which have been reported to be associated to ischemic stroke and atherosclerosis are such possible candidates.
To date, many experiments on inflammatory cytokines involved have been attempted, yet still there is continuous controversy in their significance and actual role in this multifactorial disease. Furthermore, no systematic study on the Korean population has yet been attempted. Therefore, the purposes of this study were to investigate and compare the expression of inflammatory markers, matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1) and high-sensitive C-reactive protein (hs-CRP) in Korean ischemic stroke patients and to investigate the relationship between inflammatory marker expression and apoE polymorphism. Comparison of clinical risk factors, inflammatory marker levels, and apoE genotypes between the stroke patient group and control group and between the two patient subgroups was assessed by chi-square test for nominal variables and student's t test for continuous variables. Reported P values were considered statistically significant at P<0.05. Statistical analysis was performed using the SPSS for Windows version 11.0 (SPSS Inc., Chicago, USA).
MATERIALS AND METHODS
cases. The sex ratio was 181:94 and the median age was 62.5±8.9 yr. There was no significant difference in age between the ischemic stroke and control groups. There were no significant differences in the frequencies of risk factors such as hypertension, DM, previous stroke and IHD between the LAA and SAO subgroups ( Table 1 ).
Expression of inflammatory markers
Comparison of the stroke group to control group showed significantly elevated levels of circulating MMP-9 (P= 0.00) and hs-CRP (P=0.01). Although statistically insignificant (P=0.06), TIMP-1 levels were apparently higher *, between LAA and SAO; � , between ischemic stroke and control group. Hs-CRP (mg/mL) P=0.10 Fig. 1 . Inflammatory marker levels between 4/non-4 carriers and 2/non-2 carriers in ischemic stroke group and control group.
non-E4 carrier E2 carrier non-E2 carrier ever no statistical differences in MMP-9 and hs-CRP levels were observed between the two subgroups ( Table 2 ).
Relationship of inflammatory markers and apoE polymorphism
Data analysis revealed no significant differences in inflammatory marker levels among each allele carrier, although all markers showed a tendency of elevated levels in the 2 and 4 carrier compared to the 3 carrier group (data not shown).
A comparative study of marker levels according to the presence or absence of specific alleles was done and all inflammatory markers did not show any difference between allele carriers and non-carriers in the control group, as expected. However, in the stroke patient group, MMP-9 showed significantly increased levels in 2 carriers compared to the non 2-carriers (Table 3 ). Subgroup study showed 2 carriers to have higher levels of MMP-9 and hs-CRP in the LAA subgroup compared to the non 2carriers in this group. Such relationship was not noted in the SAO subgroup (Table 4) Comparison between patient group and control group among 2 carriers showed significantly higher levels of hs-CRP in the patient group (P=0.04)( Table 3 , Fig. 1 ).
Subgroup comparison also revealed a higher level of hs-CRP in the LAA subgroup compared to the SAO subgroup (Table 4 , Fig. 2 ).
DISCUSSION
Stroke is a major cause of hospitalization, disability, and death in our society [13] . The cellular pathologic mechanisms involved in ischemic brain damage are still incompletely understood [14, 15] . Although a considerable amo- with underlying cardiovascular disease [20] [21] [22] [23] [24] .
Our study revealed increase in MMP-9 and hs-CRP levels in the ischemic stroke group. TIMP-1, although not statistically significant, displayed an increasing tendency in level expression in the patient group. An interesting finding was the increase of TIMP-1 in LAA subgroup, in comparison with the SAO subgroup. Along with the reports that show increased levels in arterial calcification, a marker correlating to plaque burden, these results support the careful speculation that TIMP-1 may play a role in the pathogenesis of atherosclerosis [19] . However, athe- the previous studies that state the limitation of sensitivity and specificity of an individual marker, a panel of markers rather than a single marker would be useful for clinical settings [13, 25] . Further studies employing other inflammatory markers as a potential index for the diagno-sis and management of ischemic stroke patients are essential and our results should be of value as baseline data in such studies. Such further study should also be helpful in understanding the mechanism of atherosclerotic pa- 
